Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah; Andrew Lin; Ryan Schofield; Caitlin Sarubbi; Elaina V. Preston; Sean M. Devlin; Valkal Bhatt; Stephen Harnicar; Elizabeth Hoover; David J. Chung; Parastoo B. Dahi; Guenther Koehne; Roni Tamari; Poguang Wang; Roger Giese; Dean Carlow; Sergio A. Giralt; Heather Landau

doi:10.1016/j.bbmt.2017.12.072

Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah
, Andrew Lin
, Ryan Schofield
, Caitlin Sarubbi
, Elaina V. Preston
, Sean M. Devlin
, Valkal Bhatt
, Stephen Harnicar
, Elizabeth Hoover
, David J. Chung
, Parastoo B. Dahi
, Guenther Koehne
, Roni Tamari
, Poguang Wang
, Roger Giese
, Dean Carlow
, Sergio A. Giralt
, Heather Landau

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1016/j.bbmt.2017.12.072
State	Published - Mar 1 2018
Event	Biology of Blood and Marrow Transplantation - Duration: Jan 1 2020 → …

Conference

Conference	Biology of Blood and Marrow Transplantation
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences

Access to Document

10.1016/j.bbmt.2017.12.072License: Unspecified

Cite this

Shah, G. L., Lin, A., Schofield, R., Sarubbi, C., Preston, E. V., Devlin, S. M., Bhatt, V., Harnicar, S., Hoover, E., Chung, D. J., Dahi, P. B., Koehne, G., Tamari, R., Wang, P., Giese, R., Carlow, D., Giralt, S. A., & Landau, H. (2018). Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT). Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2017.12.072

Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT). / Shah, Gunjan L.; Lin, Andrew; Schofield, Ryan et al.
2018. Biology of Blood and Marrow Transplantation.

Research output: Contribution to conference › Presentation

Shah, GL, Lin, A, Schofield, R, Sarubbi, C, Preston, EV, Devlin, SM, Bhatt, V, Harnicar, S, Hoover, E, Chung, DJ, Dahi, PB, Koehne, G, Tamari, R, Wang, P, Giese, R, Carlow, D, Giralt, SA & Landau, H 2018, 'Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)', Biology of Blood and Marrow Transplantation, 1/1/20. https://doi.org/10.1016/j.bbmt.2017.12.072

Shah GL, Lin A, Schofield R, Sarubbi C, Preston EV, Devlin SM et al.. Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT). 2018. Biology of Blood and Marrow Transplantation. doi: 10.1016/j.bbmt.2017.12.072

@conference{897bdec41f7c4857b77c7e00c62190db,

title = "Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela{\textregistered} (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)",

author = "Shah, \{Gunjan L.\} and Andrew Lin and Ryan Schofield and Caitlin Sarubbi and Preston, \{Elaina V.\} and Devlin, \{Sean M.\} and Valkal Bhatt and Stephen Harnicar and Elizabeth Hoover and Chung, \{David J.\} and Dahi, \{Parastoo B.\} and Guenther Koehne and Roni Tamari and Poguang Wang and Roger Giese and Dean Carlow and Giralt, \{Sergio A.\} and Heather Landau",

year = "2018",

month = mar,

day = "1",

doi = "10.1016/j.bbmt.2017.12.072",

language = "American English",

note = "Biology of Blood and Marrow Transplantation ; Conference date: 01-01-2020",

}

TY - CONF

T1 - Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

AU - Shah, Gunjan L.

AU - Lin, Andrew

AU - Schofield, Ryan

AU - Sarubbi, Caitlin

AU - Preston, Elaina V.

AU - Devlin, Sean M.

AU - Bhatt, Valkal

AU - Harnicar, Stephen

AU - Hoover, Elizabeth

AU - Chung, David J.

AU - Dahi, Parastoo B.

AU - Koehne, Guenther

AU - Tamari, Roni

AU - Wang, Poguang

AU - Giese, Roger

AU - Carlow, Dean

AU - Giralt, Sergio A.

AU - Landau, Heather

PY - 2018/3/1

Y1 - 2018/3/1

UR - https://www.bbmt.org/article/S1083-8791(17)30961-8/fulltext

U2 - 10.1016/j.bbmt.2017.12.072

DO - 10.1016/j.bbmt.2017.12.072

M3 - Presentation

T2 - Biology of Blood and Marrow Transplantation

Y2 - 1 January 2020

ER -

Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Conference

Disciplines

Access to Document

Other files and links

Cite this